Advertisement

		Daily Care News	Jump to a new section --[ Getting Around ]-- Home Page What's New Privacy Policy Search CWD --[ People ]-- Family Support Network Adults with Diabetes Care Photos Chat Rooms Conferences Kids with Diabetes Parents Parent Humor Scholarships and Financial Aid Grandparents Humorous Tidbits Jobs Mailing Lists CWD Forums Poetry and Art Videos Polls Quilt for Life Surveys Blogs --[ Clinic ]-- Ask the Diabetes Team Alternate Site Testing Alternative Treatments Care Suggestions CWD Español Diabetes Basics Diabetes at School 504 Plans Diabetes Camps Diabetes Dictionary Insulin Pumps Nutrition Podcasts Presentations Products Product Marketplace Sports Studies Warning Signs --[ Sources ]-- News and Information Diabetes Advocacy Links to Other Web Sites Press Releases Regional Information Services Support Groups --[ Feedback ]-- About CWD Advertise Awards Contribute Your Experiences Disclaimer Letters to the Editor Logos and Linking Share our Brochures

Current Daily Care News

18 November 2009

1. Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion.
2. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
3. Increased prevalence of burnout symptoms in parents of chronically ill children.
4. Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients.
5. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
6. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients.
7. A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine.
8. Deleterious associations of sitting time and television viewing time with cardio-metabolic risk biomarkers: AusDiab 2004–2005.

   11 November 2009

9. Use of insulin glargine in type 1 diabetes children with less than eight years old.
10. Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital: A Review of One Institution's Experience.
11. Effects of a Mixed Meal on Hemodynamics and Autonomic Control of the Heart in Patients with Type 1 Diabetes.
12. The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management task.
13. A Pilot Study of Observed Parenting and Adjustment in Adolescents with Type 1 Diabetes and their Mothers.

    4 November 2009

14. Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysis.
15. Family functioning at meals relates to adherence in young children with type 1 diabetes.
16. Feeding problems reported by parents of young children with type 1 diabetes on insulin pump therapy and their associations with children's glycemic control.
17. Improved metabolic outcome in a Danish diabetic paediatric population aged 0–18 yr: results from a nationwide continuous Registration.
18. The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
19. Individual Growth Curve Modeling of Specific Risk Factors and Memory in Youth with Type 1 Diabetes: An Accelerated Longitudinal Design.
20. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes.
21. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics.

    28 October 2009

22. A Pilot Trial of Pramlintide Home Usage in Adolescents With Type 1 Diabetes.
23. Microalbuminuria, preeclampsia and preterm delivery in pregnant women with type 1 diabetes - results from a nation-wide Danish study.
24. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes.
25. Optimal Insulin Treatment in Type 2 Diabetes. Free full text available in PDF format.

21 October 2009

26. Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the JDRF-CGM Trial.
27. Use of continuous glucose monitoring system in the management of severe hypoglycemia.
28. Confirmation of Hypoglycemia in the 'Dead-in-Bed' Syndrome as Captured by a Retrospective Continuous Glucose Monitoring System.
29. Nocturnal Blood Glucose and IGFBP-1 Changes in Type 1 Diabetes: Differences in the Dawn Phenomenon between Insulin Regimens.
30. Diabetic Ketoacidosis and Memory Dysfunction in Children with Type 1 Diabetes.

14 October 2009

31. Disaster Preparedness in Pediatric Type 1 Diabetes Mellitus.
32. The role of parent-adolescent attachment in the glycemic control of adolescents with type 1 diabetes: A pilot study.

    7 October 2009

33. Patterns of youths' glycemic control with insulin pump therapy.
34. Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study.
35. Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus.
36. Sexual Functioning among Women with and without Diabetes in the Boston Area Community Health Study.
37. "Diabetes Interactive Diary" (DID): a new telemedicine system enabling flexible diet and insulin therapy while improving the quality of life: an open label, international, multicentre, randomized study.
38. Postprandial Vascular Effects of Viaject™ compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus.

    30 September 2009

39. Improvements in life expectancy in type 1 diabetes patients in the last six decades.

    23 September 2009

40. Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
41. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The RealTrend study.
42. Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.
43. The Median Is Not the Only Message: A Clinician's Perspective on Mathematical Analysis of Glycemic Variability and Modeling in Diabetes Mellitus. Free full text available in HTML and PDF formats.
44. Cataract surgery in a population-based cohort of patients with type 1 diabetes: long-term incidence and risk factors.
45. Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients.
46. Daily vegetable intake during pregnancy negatively associated to islet autoimmunity in the offspring-The ABIS study.
47. Cognitive Function and Event-Related Potentials in Children With Type 1 Diabetes Mellitus.
48. Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy.

    16 September 2009

49. Emphasis on Carbohydrates May Negatively Influence Dietary Patterns in Youth with Type 1 Diabetes.
50. Managing type 1 diabetes: trends and outcomes over 20 years in the Wisconsin Diabetes Registry cohort.
51. Healthcare routines of university students with Type 1 diabetes.
52. Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements. (PDF)
53. Clinically Significant Disagreement between Mean Blood Glucose and Estimated Average Glucose in Two Populations: Implications for Diabetes Management. (PDF)
54. Comparison of Lancing Devices for Self-Monitoring of Blood Glucose Regarding Lancing Pain. (PDF)
55. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
56. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.

    9 September 2009

57. Salivary Antioxidants in Patients With Type 1 or 2 Diabetes and Inflammatory Periodontal Disease: A Case-Control Study.
58. Diabetes-specific family conflict and psychological distress in paediatric Type 1 diabetes.
59. Hub-and-spoke model for a 5-day structured patient education programme for people with Type 1 diabetes.

    2 September 2009

60. Hospitalization Subsequent to Diagnosis in Young Patients With Diabetes in Chicago, Illinois.
61. Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.
62. An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
63. Severe hypoglycaemia during pregnancy in women with Type 1 diabetes is common and planning pregnancy does not decrease the risk.
64. Initial insulin therapy in children and adolescents with type 1 diabetes mellitus.
65. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.
66. Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus.

    26 August 2009

67. Psychosocial problems in adolescents with type 1 diabetes mellitus.
68. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
69. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
70. Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational diving.
71. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.
72. Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control.

    19 August 2009

73. Sustained Benefit of Continuous Glucose Monitoring on HbA1c, Glucose Profiles, and Hypoglycemia in Adults with Type 1 Diabetes.
74. Factors Predictive of Use and of Benefit from Continuous Glucose Monitoring in Type 1 Diabetes.
75. The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes.
76. Blunted Counter-regulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents with Well-controlled Type 1 Diabetes.
77. Anxiety Symptoms in Adolescents with Type 1 Diabetes: Association with Blood Glucose Monitoring and Glycemic Control.
78. Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach.
79. Obstetric and perinatal outcomes in type 1 diabetic pregnancies – a large, population-based study.

    12 August 2009

80. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.
81. Insulin therapy and quality of life. A review.
82. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil.

    5 August 2009

83. Evidence-based insulin treatment in type 1 diabetes mellitus.
84. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus-a large-scale multicentre pilot study.
85. Living with type 1 diabetes: perceptions of children and their parents.
86. Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth Study.
87. Does brittle diabetes exist as a clinical entity? Free Portuguese language full text available in HTML and PDF formats.
88. Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands.
89. Pregnancy Outcomes in Diabetes Subtypes: How Do They Compare? A Province-based Study of Ontario, 2005-2006.
90. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

    29 July 2009

91. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration. See also Intensive Glucose Control Halves Complications of Longstanding Type 1 Diabetes, Clinical Course of Type 1 Diabetes Called Much Improved and Tight Management of Type 1 Diabetes Worth the Effort; Rates of serious complications drop with intensive therapy, study shows.
92. Benefits of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Previously Treated with Multiple Daily Injections with Once-daily Glargine and Pre-meal Analogues.
93. Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: Associations with illness characteristics and parent functioning.
94. Dyadic measures of the parent-child relationship during the transition to adolescence and glycemic control in children with type 1 diabetes.
95. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.

    22 July 2009

96. Insulin Glargine and Cancer—An Unsubstantiated Allegation.
97. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
98. Continuous glucose monitoring in youth with type 1 diabetes.
99. Associations of Parent Coping, Stress, and Well-Being in Mothers of Children with Diabetes: Examination of Data from a National Sample.
100. Compensatory beliefs about glucose testing are associated with low adherence to treatment and poor metabolic control in adolescents with type 1 diabetes.
101. Changes in Visual Impairment Prevalence by Period of Diagnosis of Diabetes The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
102. Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes.
103. Abnormal cold perception in the lower limbs: A sensitive indicator for detection of polyneuropathy in patients with type 1 diabetes mellitus.
104. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study.
105. Diabetes mellitus and gastric emptying: questions and issues in clinical practice.
106. Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome.

     15 July 2009

107. Nocturnal hypoglycaemia in type 1 diabetes--frequency and predictive factors.
108. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes.
109. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.
110. Does Diabetes Double the Risk of Depression? Free full text available in HTML and PDF formats.
111. Periodontal status in children and adolescents with type 1 diabetes mellitus.
112. Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes.
113. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
114. Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus.
115. Experiences of professional support during pregnancy and childbirth - a qualitative study of women with type 1 diabetes. Free full text available in PDF format.
116. Insulin analogs and pregnancy: an update.
117. The effect of telemedicine on outcome and quality of life in pregnant women with diabetes.

     1 July 2009

118. From Diabetelogia, the journal of the European Association for the Study of Diabetes: Lantus insulin: a possible link with cancer which requires further investigation. The science and a statement from Sanofi-Aventis are freely available at that link in PDF form. See also Sanofi-aventis stands behind the safety of Lantus® (PDF), Lantus®: message from Dr. Jean-Pierre Lehner, sanofi-aventis Chief Medical Officer (video and PDFs), European Medicines Agency update on safety of insulin glargine (PDF), European Public Assessment report on Lantus (PDF), Points to consider on the Non-clinical assessment of the carcinogenic potential of human insulin analogues (PDF) from 2001, Statement from the American Diabetes Association Related to Studies Published in 'Diabetelogia', and Companies counter insulin safety concerns.
119. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.
120. Continuous subcutaneous insulin infusion versus multiple daily injections.
121. Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1 diabetes.
122. The establishment of a new national network leads to quality improvement in childhood diabetes: Implementation of the ISPAD Guidelines.
123. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
124. Pediatric Type 1 Diabetes Linked to Excess Weight.
125. High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus.
126. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin.

     24 June 2009

127. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicentre analysis of 14,664 patients from 106 institutions.
128. Effects of a Higher-Carbohydrate/Lower-Fat Diet Versus a Lower-Carbohydrate/Higher-Fat-Monounsaturated Diet on Postmeal Triglyceride Concentrations and other Cardiovascular Risk Factors in Type 1 Diabetes.
129. Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes.
130. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
131. Short sleep duration is associated with blood pressure non dipping pattern in type 1 diabetes: The DIAPASOM study.
132. Follow-up results on monitoring and discussing health-related quality of life in adolescent diabetes care: benefits do not sustain in routine practice.
133. First Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes.
134. Disparities in self-monitoring of blood glucose among low-income ethnic minority populations with diabetes, United States.

     17 June 2009

135. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology.
136. Insulin pump for treatment of children and adolescents with diabetes. Free Norwegian language full text available in HTML format.
137. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: Should payer source influence the choice of therapy?
138. Monitoring of 24-h ECG and glucose level for detection of relations between glycemia and QT interval duration in type 1 diabetics.
139. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.

     10 June 2009

140. Type 1 diabetes mellitus and school: a comparison of patients and healthy siblings.
141. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis.
142. Feeding problems reported by parents of young children with type 1 diabetes on insulin pump therapy and their associations with children's glycemic control.
143. Effects of different antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes.
144. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study.
145. Tubular and glomerular injury in diabetes and the impact of ACE inhibition.
146. Frequency and motives of blood glucose self-monitoring in type 1 diabetes.
147. Adherence and Glycemic Control among Hispanic Youth with Type 1 Diabetes: Role of Family Involvement and Acculturation.
148. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes.

     3 June 2009

149. Continuous glucose monitoring beneficial for adults, children with well-controlled type 1 diabetes comments on The Effect of Continuous Glucose Monitoring in Well-controlled Type 1 Diabetes, previously reported.
150. Changes in Basal Insulin Infusion Rates with CSII: Time until a Change in Metabolic Effect is Induced in Patients with Type 1 Diabetes.
151. The effects of acute insulin-induced hypoglycemia on spatial abilities in adults with type 1 diabetes.
152. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
153. Difficulties or mistakes in diagnosing type 1 diabetes in children?—demographic factors influencing delayed diagnosis.
154. Adult stature and diabetic complications in patients with type 1 diabetes.
155. Everyday experience of families three years after diagnosis of type 1 diabetes in children: a research paper.
156. Adherence to the DASH Diet is Inversely Associated with Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study.

[ Current Daily Care News | News from 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

		Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Page     Print Format
			Jump to a new section --[ Getting Around ]-- Home Page What's New Privacy Policy Search CWD --[ People ]-- Family Support Network Adults with Diabetes Care Photos Chat Rooms Conferences Kids with Diabetes Parents Parent Humor Scholarships and Financial Aid Grandparents Humorous Tidbits Jobs Mailing Lists CWD Forums Poetry and Art Videos Polls Quilt for Life Surveys Blogs --[ Clinic ]-- Ask the Diabetes Team Alternate Site Testing Alternative Treatments Care Suggestions CWD Español Diabetes Basics Diabetes at School 504 Plans Diabetes Camps Diabetes Dictionary Insulin Pumps Nutrition Podcasts Presentations Products Product Marketplace Sports Studies Warning Signs --[ Sources ]-- News and Information Diabetes Advocacy Links to Other Web Sites Press Releases Regional Information Services Support Groups --[ Feedback ]-- About CWD Advertise Awards Contribute Your Experiences Disclaimer Letters to the Editor Logos and Linking Share our Brochures

Last Updated: Wed Nov 18 13:39:39 2009
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.
© Children with Diabetes, Inc. 1995-2009. Comments and Feedback.